Maternal immunoglobulin treatment can reduce severity of fetal acetylcholine receptor antibody-associated disorders (FARAD)

Abstract Background Fetal acetylcholine receptor antibody-associated disorders (FARAD), caused by in utero exposure to maternal antibodies directed against the fetal acetylcholine receptor (AChR), is a rare condition occurring in newborns of myasthenic mothers. Only two cases of FARAD children born...

Full description

Bibliographic Details

Published in:	Neurological Research and Practice
Main Authors:	Matthias Wassenberg, Andreas Hahn, Anna Mück, Heidrun H. Krämer
Format:	Article
Language:	English
Published:	BMC 2023-10-01
Subjects:	Fetal acetylcholine receptor inactivation syndrome Fetal acetylcholine receptor antibody-associated disorders Myasthenia gravis Neuromuscular disorders
Online Access:	https://doi.org/10.1186/s42466-023-00280-6